SEI Investments’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
ACM
RA
BPC
AIC
SCM
SAM
SEI Investments's SOPH Position: Q2 2026 in Review
SEI Investments reduced its SOPHiA GENETICS (SOPH) stake by 54% in Q2 2026, selling an estimated $978K and leaving 165,045 shares worth $952K. The position accounts for ﹤0.01% of the portfolio, ranked #2319.
SEI Investments first reported a position in SOPH in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.77M in Q1 2026. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- SEI Investments held 165,045 shares of SOPHiA GENETICS worth $952K as of Q2 2026.
- SEI Investments sold 192,843 SOPHiA GENETICS shares in Q2 2026, an estimated $978K.
- SOPHiA GENETICS made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2319 holding.
- SEI Investments first reported a position in SOPHiA GENETICS in Q1 2026 and has held it in 2 quarters since.
- SEI Investments's SOPHiA GENETICS position peaked at $1.77M in Q1 2026.
- 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.